Perspective: The precision-oncology illusion
- 7 September 2016
- journal article
- Published by Springer Science and Business Media LLC in Nature
- Vol. 537 (7619), S63
- https://doi.org/10.1038/537s63a
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Association of Biomarker-Based Treatment Strategies With Response Rates and Progression-Free Survival in Refractory Malignant NeoplasmsJAMA Oncology, 2016
- Characteristics of Exceptional or Super Responders to Cancer DrugsMayo Clinic Proceedings, 2015
- Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trialThe Lancet Oncology, 2015
- Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical TrialsJournal of Clinical Oncology, 2015
- Genome Sequencing Identifies a Basis for Everolimus SensitivityScience, 2012